RBOT Vicarious Surgical Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1812173 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY20.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-177.5%
ROA-115.0%
ROIC (approx.)-178.7%
Asset turnover—
Leverage & solvency
Liabilities / assets49.7%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.90x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| R&D expense | $33.60M | $40.16M | $47.58M | $43.90M | $22.06M |
| SG&A expense | $15.20M | $21.88M | $26.86M | $29.71M | $13.20M |
| Operating income | -$50.03M | -$66.56M | -$80.67M | -$80.08M | -$38.22M |
| Interest expense | — | — | $25,000 | $200,000 | $89,000 |
| Pretax income | -$50.18M | -$63.22M | -$71.07M | $5.16M | -$35.21M |
| Net income | -$50.18M | -$63.22M | -$71.07M | $5.16M | -$35.21M |
| EBITDA | -$48.60M | -$64.45M | -$78.81M | -$78.97M | -$37.91M |
| EPS (basic) | — | — | -0.49 | 0.04 | -0.36 |
| EPS (diluted) | — | — | -0.49 | 0.04 | -0.36 |
| Weighted avg. shares (diluted) | 6.13M | 5.89M | 4.87M | 127.53M | 96.69M |
| Balance sheet | |||||
| Cash & equivalents | $2.57M | $9.74M | $53.76M | $117.14M | $174.56M |
| Short-term investments | $7.22M | $39.36M | $45.35M | — | — |
| Current assets | $11.58M | $51.70M | $100.95M | $120.40M | $178.37M |
| PP&E, net | $1.27M | $4.48M | $6.40M | $6.59M | $2.25M |
| Total assets | $19.58M | $67.72M | $119.86M | $140.29M | $181.68M |
| Current liabilities | $3.90M | $7.67M | $7.28M | $8.39M | $6.25M |
| Long-term debt | — | — | $2.00M | — | $675,000 |
| Total debt | — | — | $2.00M | — | $675,000 |
| Total liabilities | $9.74M | $21.02M | $21.89M | $29.25M | $98.59M |
| Shareholders' equity | $9.84M | $46.70M | $97.97M | $111.05M | $83.09M |
| Net debt | — | — | -$51.76M | — | -$173.89M |
| Cash flow statement | |||||
| Operating cash flow | -$45.08M | -$49.96M | -$62.30M | -$61.21M | -$33.30M |
| Capital expenditure | $132,000 | $180,000 | $1.67M | $5.35M | $1.29M |
| Free cash flow | -$45.21M | -$50.14M | -$63.98M | -$66.56M | -$34.59M |
| Investing cash flow | $32.15M | $6.86M | -$45.78M | -$5.35M | -$1.29M |
| Financing cash flow | $5.76M | $8,000 | $44.70M | $9.14M | $192.16M |
| Depreciation & amortization | $1.43M | $2.11M | $1.85M | $1.11M | $316,000 |
| Stock-based compensation | $8.13M | $11.90M | $13.27M | $12.26M | $3.69M |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.